Cristoforo Silvestri
Overview
Explore the profile of Cristoforo Silvestri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dudek K, Paton S, Binder L, Collignon A, Dion-Albert L, Cadoret A, et al.
Nat Neurosci
. 2025 Feb;
PMID: 40016352
Blood-brain barrier (BBB) alterations contribute to stress vulnerability and the development of depressive behaviors. In contrast, neurovascular adaptations underlying stress resilience remain unclear. Here we report that high expression of...
2.
Palomba L, Silvestri C, Silvestri E
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1522613.
PMID: 39691314
No abstract available.
3.
Mboumba Bouassa R, Giorgini G, Silvestri C, Muller C, Nallabelli N, Alexandrova Y, et al.
iScience
. 2024 Aug;
27(8):110456.
PMID: 39156649
Chronic HIV infection is associated with accelerated coronary artery disease (CAD) due to chronic inflammation. The expanded endocannabinoid system (eCBome) and gut microbiota modulate each other and are key regulators...
4.
Roussel C, Sola M, Lessard-Lord J, Nallabelli N, Genereux P, Cavestri C, et al.
Gut Microbes
. 2024 May;
16(1):2335879.
PMID: 38695302
Dietary omega-3 polyunsaturated fatty acids (-3 PUFAs) and the gut microbiome affect each other. We investigated the impact of supplementation with oil (BO), rich in stearidonic acid (SDA), on the...
5.
Guida F, Iannotta M, Perrone M, Infantino R, Giorgini G, Fusco A, et al.
Biomed Pharmacother
. 2024 Apr;
175:116600.
PMID: 38670046
There is a growing evidence suggesting the association of vitamin D deficiency (VDD) and cognitive impairment. In this study we evaluated the possible involvement of gut microbiota in the cognitive...
6.
Dridi C, Millette M, Salmieri S, Aguilar Uscanga B, Lacroix S, Venneri T, et al.
Foods
. 2024 Jan;
13(2).
PMID: 38254505
The health and balance of the gut microbiota are known to be linked to diet composition and source, with fermented products and dietary proteins potentially providing an exceptional advantage for...
7.
Lessard-Lord J, Lupien-Meilleur J, Roussel C, Gosselin-Cliche B, Silvestri C, Di Marzo V, et al.
FASEB J
. 2024 Jan;
38(2):e23398.
PMID: 38214938
In vitro systems are widely employed to assess the impact of dietary compounds on the gut microbiota and their conversion into beneficial bacterial metabolites. However, the complex fluid dynamics and...
8.
Forte N, Roussel C, Marfella B, Lauritano A, Villano R, De Leonibus E, et al.
Commun Biol
. 2023 Sep;
6(1):959.
PMID: 37735539
N-oleoylglycine (OlGly), a lipid derived from the basic component of olive oil, oleic acid, and N-oleoylalanine (OlAla) are endocannabinoid-like mediators. We report that OlGly and OlAla, by activating the peroxisome...
9.
Boubertakh B, Courtemanche O, Marsolais D, Di Marzo V, Silvestri C
J Lipid Res
. 2023 Sep;
64(11):100444.
PMID: 37730163
White adipose tissue regulation is key to metabolic health, yet still perplexing. The chief endocannabinoid anandamide metabolite, prostaglandin F ethanolamide (PGFEA), inhibits adipogenesis, that is, the formation of mature adipocytes....
10.
Venneri T, Giorgini G, Leblanc N, Flamand N, Borrelli F, Silvestri C, et al.
Lipids Health Dis
. 2023 May;
22(1):63.
PMID: 37189092
Background: Gut microbiota are involved in the onset and development of chronic intestinal inflammation. The recently described endocannabinoidome (eCBome), a diverse and complex system of bioactive lipid mediators, has been...